Rankings
▼
Calendar
KYMR FY 2020 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
KYMR
Kymera Therapeutics, Inc.
$7B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$34M
+1060.0% YoY
Gross Profit
$34M
100.0% margin
Operating Income
-$46M
-136.1% margin
Net Income
-$46M
-134.0% margin
EPS (Diluted)
$-0.99
Cash Flow
Operating Cash Flow
$88M
Free Cash Flow
$79M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$487M
Total Liabilities
$203M
Stockholders' Equity
$284M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$3M
+1060.0%
Gross Profit
$34M
$2M
+1513.8%
Operating Income
-$46M
-$42M
-9.7%
Net Income
-$46M
-$41M
-10.4%
← Q4 2019
All Quarters
Q1 2020 →